UBS assumed coverage of Aflac (AFL) with a Neutral rating and price target of $114, up from $109. The firm is “cautiously positive” on the life insurance sector, citing “key positives” such as higher-for-longer interest rate environment, which it believes is favorable fundamentally and sentiment-wise, and balance sheet strength. Recent accounting changes have improved investor comfort around macro-related balance sheet assumptions in prior cycles, the analyst tells investors in a research note.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFL:
- Aflac price target raised to $124 from $118 at Piper Sandler
- Globe Life price target raised to $152 from $140 at Piper Sandler
- Cautious Hold Rating on AFLAC Amid Sector Challenges and Mixed Business Trends
- Aflac price target raised to $96 from $94 at JPMorgan
- Aflac price target raised to $105 from $98 at Morgan Stanley